Related Experiment Video
Updated: Aug 10, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 10, 2011
Vaccines and immunotherapy for staphylococcal infections
1Inhibitex, Inc., Alpharetta, Georgia, USA. jpatti@inhibitex.com
The International Journal of Artificial Organs
|December 15, 2005
Summary
Hospital-acquired infections increase costs and hospital stays. This review explores bacterial adhesins and new immunological therapies for staphylococcal infections, offering potential solutions for these challenging healthcare-associated infections.
Area of Science:
- Infectious Diseases
- Immunology
- Biomedical Engineering
Background:
- Nosocomial infections prolong hospital stays and escalate healthcare expenses.
- Surgical implant-associated infections present significant management challenges, demanding complex treatments and increased costs.
- Rising use of medical devices, immunocompromised populations, and antibiotic resistance necessitate novel infection prevention and treatment strategies.
Purpose of the Study:
- To provide an overview of bacterial adhesins.
- To focus on novel immunological therapies for staphylococcal infections.
- To address the growing challenge of hospital-acquired infections.
Main Methods:
- Literature review of bacterial adhesins.
- Analysis of current research on immunological therapies.
- Synthesis of information on staphylococcal infection management.
Main Results:
- Bacterial adhesins play a crucial role in infection development.
- Immunological approaches show promise in combating staphylococcal infections.
- Novel therapies are being developed to target key bacterial mechanisms.
Conclusions:
- Understanding bacterial adhesins is key to developing effective treatments.
- Immunological strategies offer a promising avenue for managing staphylococcal infections.
- Continued research into novel therapies is essential for reducing the burden of nosocomial infections.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

